文献速递妇科

尿液黏附分子作为子宫内膜异位症诊断生物标志物的研究

Investigating selected adhesion molecules as urinary biomarkers for diagnosing endometriosis.
PubMed 文献 · Reprod Biomed Online · 2020-01-25

这项前瞻性纵向研究纳入149例因良性妇科疾病行腹腔镜手术且至少3个月未接受激素治疗的患者,检测术前尿液中sVCAM-1、sICAM-1、E-选择素和P-选择素的肌酐校正水平。结果显示,子宫内膜异位症组(n=84)与无子宫内膜异位症组(n=65)之间上述尿液标志物水平无差异,ROC分析亦无显著性,血清与尿液sVCAM-1/sICAM-1水平无显著相关性。

要点

  • 尿液sVCAM-1、sICAM-1、E-选择素和P-选择素在子宫内膜异位症与无子宫内膜异位症女性间无差异。
  • 上述标志物及sVCAM/sICAM比值用于诊断子宫内膜异位症的ROC分析均不显著。
  • 血清与尿液sVCAM或sICAM水平在同一女性中无显著相关性。

核心结论

  • 尿液中sVCAM-1、sICAM-1、E-选择素和P-选择素水平在子宫内膜异位症与无子宫内膜异位症女性间无显著差异。
  • 上述尿液标志物及sVCAM/sICAM比值不能用于诊断子宫内膜异位症。

研究设计与样本

  • 前瞻性纵向研究(Endometriosis Marker Austria),纳入因良性妇科疾病行腹腔镜手术的患者。
  • 共纳入149例患者,招募前至少3个月未接受激素治疗。
  • 术前采用磁珠多重检测法测定尿液sVCAM-1、sICAM-1、E-选择素和P-选择素,并按肌酐水平归一化。

主要发现

  • 子宫内膜异位症组84例与无子宫内膜异位症组65例的尿液sVCAM-1、sICAM-1、E-选择素和P-选择素水平无差异,亚组间亦无差异。
  • 以sVCAM-1、sICAM-1、E-选择素、P-选择素水平及sVCAM/sICAM比值诊断子宫内膜异位症的ROC分析均不显著。
  • 同一女性血清与尿液sVCAM或sICAM水平无显著相关性。

临床怎么用

  • 不建议将尿液sVCAM-1、sICAM-1、E-选择素或P-选择素作为子宫内膜异位症的诊断标志物。
  • 需继续研究其他标志物以建立真正无创的尿液诊断试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Are selected cell adhesion molecules useful as urinary biomarkers for diagnosing endometriosis? DESIGN: Prospective, longitudinal study (the Endometriosis Marker Austria) in patients who underwent laparoscopic surgery for benign gynaecological pathologies. A total of 149 patients not receiving hormonal treatment for at least 3 months prior to recruitment were included and preoperative urine protein levels of soluble vascular adhesion molecule-1 (sVCAM-1), soluble intracellular adhesion molecule-1 (sICAM-1), E-selectin and P-selectin were measured using a magnetic bead-based multiplex assay, normalized to creatinine levels of each sample. Levels were correlated with endometriosis status, menstrual cycle phase, body mass index, cigarette smoking and severity and entity of the lesions. RESULTS: Urine levels of sVCAM-1, sICAM-1, E-selectin and P-selectin did not differ between women with (n = 84) and without (n = 65) endometriosis and among subgroups. Accordingly, receiver operating characteristic analysis to examine the value of using sVCAM-1, sICAM-1, E-selectin and P-selectin levels and sVCAM/sICAM ratio to diagnose endometriosis were not significant. Whether the serum sVCAM-1 levels correlated with the urine levels of the protein in the same women was also investigated, which revealed no significant correlations for sVCAM or sICAM. CONCLUSION: Although a previous study had suggested that serum sVCAM is a promising biomarker for diagnosing endometriosis, no significant differences were found in urine levels of sVCAM-1, sICAM-1, E-selectin and P-selectin between women with and without endometriosis. Other markers should be studied in an effort to establish a truly non-invasive urinary test for diagnosing endometriosis.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Proestling K, Wenzl R, Yotova I, et al. Investigating selected adhesion molecules as urinary biomarkers for diagnosing endometriosis. Reprod Biomed Online. 2020. PMID: 32220518. doi:10.1016/j.rbmo.2020.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。